Company attributes
Other attributes
Pheronym is a biotechnology company located in Davis, California and is founded by Dr. Fatma Kaplan and Karl Cameron Schillermaking. Pheronym makes pheromone-like molecules for pest control, which control behavior in parasitic nematodes by driving them away from plants and towards insects. The company claims their pheromone technology—when applied to nematodes—results in a 5X increase in targeted insect kill rates compared to untreated nematodes; while non-target insects remain safe, and no harmful residues are left in the environment.
Nemastim is a pheromone product that is used to treat commercial nematodes used for pest control and can be sprayed using regular pesticide/herbicide spraying equipment. When commercial nematodes are treated with Nemastim, they are stimulated to search for and kill insect pests. The application of Nemastim is broad spectrum, meaning it stimulates nematodes to attack twenty eight known pests. Nemastim makes nematodes target and kill insects for the following crop varieties: almonds, apricots, cherries, cucumbers, oranges, peaches. pecans, tomatoes, and many more.
CEO and founder of Pheronym Dr. Fatma Kaplan, along with a team of scientists from the University of Florida, won the 2018: Florida Department of Agriculture & Consumer Services: Specialty Crop Block Grant Award for their research proposal titled "Nematode-resistant pepper varieties for Florida".
On October 18, 2017, Pheronym was awarded a $100,000 USDA-SBIR Phase I grant to support further research into the development and application of Pheronym's pheromone technology.
On March 30, 2017, Pheronym was accepted into IndieBio's 4.5 month-long accelerator program, receiving $250,000 in funding from IndieBio and SOSV.
On February 20, 2019, Pheronym announced they received a grant worth $100,000 from the International Space Station (ISS) US National Laboratory. After receiving this grant, Pheronym became the first company in the world to have a contract for an agricultural bio-control experiment that will take place in space. The project director and CEO of Pheronym, Dr. Fatma Kaplan, made the following public statement after the company's grant announcement:
We are looking to duplicate in space the success of our earth-bound commercialization trials of our nematode focused bio-remediation. Our only regret is we can’t join our nematodes for their trip to the Space Station.